• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其胃肠病学家对肥胖的认知和态度:由土耳其胃肠病学协会肥胖研究小组进行的全国性调查。

Perception and Attitude of Turkish Gastroenterologists Toward Obesity: A Nationwide Survey Conducted by the Obesity Study Group of the Turkish Gastroenterology Association.

机构信息

Department of Gastroenterology, Yıldırım Beyazıt University, Faculty of Medicine, Ankara, Turkey.

Depatment of Gastroenterology, Memorial Hospital, İstanbul, Turkey.

出版信息

Turk J Gastroenterol. 2024 Mar;35(3):161-167. doi: 10.5152/tjg.2024.22733.

DOI:10.5152/tjg.2024.22733
PMID:39128109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11059572/
Abstract

BACKGROUND/AIMS: Gastroenterologists have an important role in the treatment and management of comorbidities related to obesity. Assessment of gastroenterologists' perception and attitude toward obesity was aimed in this study.

MATERIALS AND METHODS

Survey questions were determined for the study. An online questionnaire was prepared afterward. Participants were invited via e-mail by providing them with information about the study. It was ensured that those who accepted the study could access the questionnaire form with the relevant link. Participants who answered all questions were included in the study.

RESULTS

Totally 117 gastroenterologists were included in the study. The proportion of gastroenterologists who thought that obesity complicates the management of gastroenterological diseases and those who thought obesity as a factor that negatively affects the prognosis of gastroenterological diseases was determined as 88.9% and 95.7%, respectively. Among the obese patients, the proportion of those who applied diet therapy, exercise, pharmacotherapy, and endoscopic methods was 94%, 91.5%, 35%, and 37.6%, respectively. The rates of intragastric balloon therapy and intragastric botulinum toxin A injection were 30% and 21.4%, respectively. The proportion of those who agreed that obese patients lost a significant amount of weight with the treatment methods applied was 47.2%. The proportion of participants who agreed that long-term maintenance of weight loss was impossible for most obese patients was 59.8%.

CONCLUSION

To our knowledge, this is the first study that evaluates the perception and attitude of gastroenterologists toward obesity. Our study results show that gastroenterologists think that obesity is a chronic disease and that gastroenterologists should be involved in management of obesity.

摘要

背景/目的:胃肠病学家在治疗和管理肥胖相关合并症方面发挥着重要作用。本研究旨在评估胃肠病学家对肥胖的看法和态度。

材料和方法

为研究确定了调查问题。随后准备了在线问卷。通过向参与者提供有关研究的信息,通过电子邮件邀请他们参加。确保那些接受研究的人可以通过相关链接访问问卷表。回答所有问题的参与者被纳入研究。

结果

共有 117 名胃肠病学家参与了这项研究。认为肥胖使胃肠病学疾病的管理复杂化和认为肥胖是影响胃肠病学疾病预后的负面因素的胃肠病学家的比例分别为 88.9%和 95.7%。在肥胖患者中,应用饮食疗法、运动、药物治疗和内镜方法的比例分别为 94%、91.5%、35%和 37.6%。胃内球囊治疗和胃内肉毒毒素 A 注射的比例分别为 30%和 21.4%。认为肥胖患者通过应用的治疗方法减轻了大量体重的参与者比例为 47.2%。认为大多数肥胖患者不可能长期维持体重减轻的参与者比例为 59.8%。

结论

据我们所知,这是第一项评估胃肠病学家对肥胖看法和态度的研究。我们的研究结果表明,胃肠病学家认为肥胖是一种慢性疾病,胃肠病学家应该参与肥胖的管理。

相似文献

1
Perception and Attitude of Turkish Gastroenterologists Toward Obesity: A Nationwide Survey Conducted by the Obesity Study Group of the Turkish Gastroenterology Association.土耳其胃肠病学家对肥胖的认知和态度:由土耳其胃肠病学协会肥胖研究小组进行的全国性调查。
Turk J Gastroenterol. 2024 Mar;35(3):161-167. doi: 10.5152/tjg.2024.22733.
2
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey.新冠疫情对青年消化科医生临床实践和培训的影响:一项欧洲调查。
Dig Liver Dis. 2020 Dec;52(12):1396-1402. doi: 10.1016/j.dld.2020.05.023. Epub 2020 May 23.
3
Current practice and perception of screening for medication adherence in inflammatory bowel disease.当前炎症性肠病药物治疗依从性筛查的实践现状和认知。
J Clin Gastroenterol. 2011 Nov-Dec;45(10):878-82. doi: 10.1097/MCG.0b013e3182192207.
4
Practices, attitudes, and knowledge about Crohn's disease and smoking cessation among gastroenterologists.胃肠病学家对克罗恩病及戒烟的做法、态度和知识
Eur J Gastroenterol Hepatol. 2018 Feb;30(2):155-160. doi: 10.1097/MEG.0000000000001010.
5
Gastroenterologists' Perceptions Regarding Ulcerative Colitis and Its Management: Results from a Large-Scale Survey.胃肠病学家对溃疡性结肠炎及其管理的看法:一项大规模调查的结果
Adv Ther. 2016 Oct;33(10):1715-1727. doi: 10.1007/s12325-016-0393-7. Epub 2016 Aug 10.
6
How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation?美国胃肠病学家如何在胃食管反流和慢性便秘患者中使用非处方药和处方药?
Am J Gastroenterol. 2015 Nov;110(11):1516-25. doi: 10.1038/ajg.2015.156. Epub 2015 Jun 9.
7
Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.罗马尼亚非酒精性脂肪性肝病/非酒精性脂肪性肝炎的真实感知和实践模式:102 名经董事会认证的胃肠病学家完成的调查结果。
J Gastrointestin Liver Dis. 2016 Jun;25(2):183-9. doi: 10.15403/jgld.2014.1121.252.naf.
8
Gastroenterologists attitude in various clinical settings in the era of COVID-19 pandemic: An online Uni-National Israeli Survey.在 COVID-19 大流行时代,胃肠病学家在各种临床环境中的态度:一项全国性的以色列在线调查。
Medicine (Baltimore). 2021 Jul 30;100(30):e26781. doi: 10.1097/MD.0000000000026781.
9
Gastroenterologists' Views of Shared Decision Making for Patients with Inflammatory Bowel Disease.胃肠病学家对炎症性肠病患者共同决策的看法。
Dig Dis Sci. 2015 Sep;60(9):2636-45. doi: 10.1007/s10620-015-3675-z. Epub 2015 May 5.
10
Chinese physicians' perceptions of fecal microbiota transplantation.中国医生对粪便微生物群移植的看法。
World J Gastroenterol. 2016 May 21;22(19):4757-65. doi: 10.3748/wjg.v22.i19.4757.

引用本文的文献

1
A culprit for carcinogenesis hiding in daylight: normal-weight obesity.隐藏在日光下的致癌元凶:正常体重肥胖症。
J Gastroenterol. 2024 Oct;59(10):958-959. doi: 10.1007/s00535-024-02142-7. Epub 2024 Aug 8.

本文引用的文献

1
Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta-analysis of randomized controlled trials.胃内注射A型肉毒杆菌毒素用于减肥:随机对照试验的系统评价和荟萃分析。
J Gastroenterol Hepatol. 2022 Jun;37(6):983-992. doi: 10.1111/jgh.15847. Epub 2022 Apr 22.
2
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study.体重指数与肥胖相关复杂多种病的风险:一项观察性多队列研究。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):253-263. doi: 10.1016/S2213-8587(22)00033-X. Epub 2022 Mar 4.
3
Impact of Obesity on Inflammatory Bowel Disease.肥胖对炎症性肠病的影响。
Curr Gastroenterol Rep. 2022 Jan;24(1):26-36. doi: 10.1007/s11894-022-00840-x. Epub 2022 Feb 12.
4
European Commission classifies obesity as a chronic disease.欧盟委员会将肥胖归类为一种慢性病。
Lancet Diabetes Endocrinol. 2021 Jul;9(7):418. doi: 10.1016/S2213-8587(21)00145-5. Epub 2021 Jun 1.
5
AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity.美国胃肠病学会关于胃内球囊治疗肥胖症的临床实践指南。
Gastroenterology. 2021 Apr;160(5):1799-1808. doi: 10.1053/j.gastro.2021.03.003.
6
Obesity in adults: a clinical practice guideline.成人肥胖:临床实践指南。
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
7
Endoscopic management of leaks and fistulas after bariatric surgery: a systematic review and meta-analysis.减重手术后漏口和瘘管的内镜治疗:一项系统评价和荟萃分析。
Surg Endosc. 2021 Mar;35(3):1067-1087. doi: 10.1007/s00464-020-07471-1. Epub 2020 Feb 27.
8
Role of Overweight and Obesity in Gastrointestinal Disease.超重和肥胖在胃肠道疾病中的作用。
Nutrients. 2019 Dec 31;12(1):111. doi: 10.3390/nu12010111.
9
New Era: Endoscopic treatment options in obesity-a paradigm shift.新时代:肥胖症的内镜治疗选择——范式转变。
World J Gastroenterol. 2019 Aug 28;25(32):4567-4579. doi: 10.3748/wjg.v25.i32.4567.
10
Gut microbiota: a new path to treat obesity.肠道微生物群:治疗肥胖的新途径。
Int J Obes Suppl. 2019 Apr;9(1):10-19. doi: 10.1038/s41367-019-0011-7. Epub 2019 Apr 12.